From Tol2Kit
Line 17: | Line 17: | ||
|5.3 kb beta-actin promoter (ubiquitous)||7950||KMK | |5.3 kb beta-actin promoter (ubiquitous)||7950||KMK | ||
|- | |- | ||
− | !380||p5E-''h2afx'' | + | !380||[[p5E-h2afx|p5E-''h2afx'']] |
|1 kb histone2A-X promoter (quasi-ubiquitous)||3604||KMK | |1 kb histone2A-X promoter (quasi-ubiquitous)||3604||KMK | ||
|- | |- | ||
− | !382||p5E-CMV/SP6 | + | !382||[[p5E-CMV/SP6]] |
|1 kb CMV/SP6 cassette from pCS2+||3704||KMK | |1 kb CMV/SP6 cassette from pCS2+||3704||KMK | ||
|- | |- | ||
− | !222||p5E-''hsp70'' | + | !222||[[p5E-hsp70|p5E-''hsp70'']] |
|1.5 kb hsp70 promoter for heat-shock induction||4163||BM | |1.5 kb hsp70 promoter for heat-shock induction||4163||BM | ||
|- | |- | ||
− | !327||p5E-UAS | + | !327||[[p5E-UAS]] |
|10x UAS element and basal promoter for Gal4 response||3127||DSC | |10x UAS element and basal promoter for Gal4 response||3127||DSC | ||
|- | |- |
Revision as of 22:09, 22 March 2007
Here is a list of the constructs in the Tol2kit. We have included crudely annotated sequences and maps for several constructs, 2/16/07. Sizes in bp have been added for all constructs, 2/20/07. Minor edits to existing sequences and slightly better versions of maps, 3/19/07.
Better-formatted information for all sequences is planned Real Soon Now.
Constructs in the Tol2kit v1 (Feb 2007)
# | name | insert | size (bp) | made by |
---|---|---|---|---|
5' entry clones, attL4-R1 (kan resistant) | ||||
299 | p5E-bactin2 | 5.3 kb beta-actin promoter (ubiquitous) | 7950 | KMK |
380 | p5E-h2afx | 1 kb histone2A-X promoter (quasi-ubiquitous) | 3604 | KMK |
382 | p5E-CMV/SP6 | 1 kb CMV/SP6 cassette from pCS2+ | 3704 | KMK |
222 | p5E-hsp70 | 1.5 kb hsp70 promoter for heat-shock induction | 4163 | BM |
327 | p5E-UAS | 10x UAS element and basal promoter for Gal4 response | 3127 | DSC |
228 | p5E-MCS | multi-cloning site from pBluescript | 2810 | BM |
381 | p5E-Fse-Asc | restriction sites for 8-cutters FseI and AscI | 2663 | EF |
middle entry clones, attL1-L2 (kan resistant) | ||||
383 | pME-EGFP | EGFP | 3327 | KMK |
384 | pME-EGFPCAAX | membrane-localized (prenylated) EGFP; fused to 21 aa of H-ras | 3345 | KMK |
385 | pME-nlsEGFP | nuclear-localized EGFP | 3342 | KMK |
386 | pME-mCherry | monomeric red fluorophore mCherry | 3261 | KMK |
232 | pME-mCherryCAAX | prenylated mCherry | 3321 | KMK |
233 | pME-nlsmCherry | nuclear-localized mCherry | 3288 | KMK |
234 | pME-H2AmCherry | mCherry fused to zebrafish histone H2A.F/Z | 3651 | KMK |
387 | pME-Gal4VP16 | Gal4 DNA binding domain fused to VP16 transactivation domain | 3204 | EF |
3' entry clones, attR2-L3 (kan resistant) | ||||
302 | p3E-polyA | SV40 late polyA signal | 2838 | KMK |
229 | p3E-MTpA | 6x myc tag for C-terminal fusions, plus SV40 late polyA | 3151 | BM |
366 | p3E-EGFPpA | EGFP for C-terminal fusions, plus SV40 late polyA | 3634 | MEH |
388 | p3E-mCherrypA | mCherry for C-terminal fusions, plus SV40 late polyA | 3586 | MEH |
389 | p3E-IRES-EGFPpA | IRES driving EGFP plus SV40 late polyA | 4219 | KMK |
390 | p3E-IRES-EGFPCAAXpA | IRES driving prenylated EGFP plus SV40 late polyA | 4250 | KMK |
391 | p3E-IRES-nlsEGFPpA | IRES driving nuclear EGFP plus SV40 late polyA | 4248 | KMK |
destination vectors, attR4-R3 (amp/chlor resistant; grow in ccdB-tolerant cells) | ||||
392 | pDestTol2pA* | attR4-R3 gate with SV40 polyA flanked by Tol2 inverted repeats | 7897 | CG |
393 | pDestTol2CG* | pDestTol2pA with cmlc2:egfp transgenesis marker | 9702 | EF |
394 | pDestTol2pA2 | pDestTol2pA with ~2 kb extraneous sequence removed | 5877 | EF |
395 | pDestTol2CG2 | pDestTol2CG2 with ~2 kb extraneous sequence removed | 7790 | EF |
transposase clones | ||||
396 | pCS2FA-transposase | for in vitro transcription of capped Tol2 transposase mRNA | 6034 | KMK |
Notes
- # is the Chien lab stock number
- made by shows who made the construct:
- CG: Clemens Grabher, Look lab
- BM: Ben Mangum, Chien lab
- DSC, Doug Campbell, Chien lab
- EF, Esther Fujimoto, Chien lab
- KMK, Kristen Kwan, Chien lab
- MEH, Melissa Hardy, Chien lab
- pDestTol2pA and pDestTol2CG have been superseded by pDestTol2pA2 and pDestTol2CG2, and are no longer being distributed.